Regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer’s disease
Acta Materia Medica · 2022
DOI: 10.15212/amm-2021-0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Materia Medica, 2022. Verfasst von Abdol-Hossein Rezaeian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Maintaining neuronal integrity and function requires precise mechanisms controlling organelle and protein quality. Alzheimer’s disease (AD) is also characterized by functional defects in the clearance and recycling of intracellular components. In fact, neuronal homeostasis involves autophagy, mitophagy, apoptosis, and compromised activity in these cellular processes may cause pathological phenotypes of AD. Therefore, mitophagy is a critical mitochondrial quality-control system, and impaired mitophagy is a hallmark of AD. Myeloid cell leukemia 1 (MCL1), a member of the pro-survival B-cell lymphoma protein 2 (BCL2) family, is a mitochondrially targeted protein that contributes to maintaining mitochondrial integrity. Mcl1 -knockout mice display peri-implantation lethality. Studies on conditional Mcl1 -knockout mice have demonstrated that MCL1 plays a central role in neurogenesis and neuronal survival during brain development. Accumulating evidence indicates the critical role of MCL1 as a regulator of neuronal autophagy, mitophagy, and survival. In this review, we discuss the emerging neuroprotective function of MCL1 and how dysregulation of MCL1 signaling is involved in the pathogenesis of AD. Because members of the pro-survival BCL2 family proteins are promising targets of pharmacological intervention with BH3 mimetic drugs, we also discuss the promise of MCL1-targeting therapy in AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Förderung
- NCI NIH HHS
Zitieren
APA
Rezaeian, A. H., Wei, W., & Inuzuka, H. (2022). Regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer’s disease. Acta Materia Medica. https://doi.org/10.15212/amm-2021-0002
Vancouver
Rezaeian AH, Wei W, Inuzuka H. Regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer’s disease. Acta Materia Medica. 2022. doi:10.15212/amm-2021-0002
BibTeX
@article{Rezaeian2022,
author = {Rezaeian, Abdol-Hossein and Wei, Wenyi and Inuzuka, Hiroyuki},
title = {Regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer’s disease},
journal = {Acta Materia Medica},
year = {2022},
doi = {10.15212/amm-2021-0002}
}
EUVIMED